Angiogenesis: The VE-cadherin switch

被引:109
作者
Wallez, Y
Vilgrain, I
Huber, P
机构
[1] CEA, DVE, DRDC, F-38054 Grenoble, France
[2] Univ Grenoble 1, Lab Dev & Viellissement Endothelium, Grenoble, France
[3] INSERM, EMI 02 19, Grenoble, France
关键词
D O I
10.1016/j.tcm.2005.11.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Because angiogenesis is a key step in a number of pathologic processes, including tumor growth and atherosclerosis, many research studies have investigated the regulatory signals active at various stages of vascular invasion. The differential activities of the endothelial junction protein vascular endothelial (VE)-cadherin reflect the versatile behavior of endothelial cells between vascular quiescence and angiogenesis. VE-cadherin function and signaling are deeply modified in proliferating cells, and this conversion is accompanied by phosphorylation of the protein on tyrosine residues and enhanced transcription of its gene. Recent advances in the complex interplay between protein tyrosme kinases and phosphatases regulating VE-cadherin phosphorylation and function are discussed in this review.
引用
收藏
页码:55 / 59
页数:5
相关论文
共 40 条
[1]   Role of interendothelial adhesion molecules in the control of vascular functions [J].
Aurrand-Lions, M ;
Johnson-Léger, C ;
Imhof, BA .
VASCULAR PHARMACOLOGY, 2002, 39 (4-5) :239-246
[2]   VE-cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels [J].
Bach, TL ;
Barsigian, C ;
Chalupowicz, DG ;
Busler, D ;
Yaen, CH ;
Grant, DS ;
Martinez, J .
EXPERIMENTAL CELL RESEARCH, 1998, 238 (02) :324-334
[3]   Association of Csk to VE-cadherin and inhibition of cell proliferation [J].
Baumeister, U ;
Funke, R ;
Ebnet, K ;
Vorschmitt, H ;
Koch, S ;
Vestweber, D .
EMBO JOURNAL, 2005, 24 (09) :1686-1695
[4]   Endothelial cell-to-cell junctions: Molecular organization and role in vascular homeostasis [J].
Bazzoni, G ;
Dejana, E .
PHYSIOLOGICAL REVIEWS, 2004, 84 (03) :869-901
[5]   FUNCTIONAL-PROPERTIES OF HUMAN VASCULAR ENDOTHELIAL CADHERIN (7B4/CADHERIN-5), AN ENDOTHELIUM-SPECIFIC CADHERIN [J].
BREVIARIO, F ;
CAVEDA, L ;
CORADA, M ;
MARTINPADURA, I ;
NAVARRO, P ;
GOLAY, J ;
INTRONA, M ;
GULINO, D ;
LAMPUGNANI, MG ;
DEJANA, E .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (08) :1229-1239
[6]   Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis [J].
Carmeliet, P ;
Lampugnani, MG ;
Moons, L ;
Breviario, F ;
Compernolle, V ;
Bono, F ;
Balconi, G ;
Spagnuolo, R ;
Oosthuyse, B ;
Dewerchin, M ;
Zanetti, A ;
Angellilo, A ;
Mattot, V ;
Nuyens, D ;
Lutgens, E ;
Clotman, F ;
de Ruiter, MC ;
Gittenberger-de Groot, A ;
Poelmann, R ;
Lupu, F ;
Herbert, JM ;
Collen, D ;
Dejana, E .
CELL, 1999, 98 (02) :147-157
[7]   Inhibition of cultured cell growth by vascular endothelial cadherin (Cadherin-5 VE-cadherin) [J].
Caveda, L ;
MartinPadura, L ;
Navarro, P ;
Breviario, F ;
Corada, M ;
Gulino, D ;
Lampugnani, MG ;
Dejana, E .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) :886-893
[8]   Src Kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells [J].
Chou, Mary T. ;
Wang, Jing ;
Fujita, Donald J. .
BMC BIOCHEMISTRY, 2002, 3 :1-11
[9]   The cadherin-catenin adhesion system in signaling and cancer [J].
Conacci-Sorrell, M ;
Zhurinsky, J ;
Ben-Ze'ev, A .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (08) :987-991
[10]   A monoclonal antibody to vascular endothehal-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability [J].
Corada, M ;
Zanetta, L ;
Orsenigo, F ;
Breviario, F ;
Lampugnani, MG ;
Bernasconi, S ;
Liao, F ;
Hicklin, DJ ;
Bohlen, P ;
Dejana, E .
BLOOD, 2002, 100 (03) :905-911